세계의 제네릭 의약품 시장 : 유형별, 투여 경로별, 제품별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2023-2030년)

Generic Pharmaceuticals Market with COVID-19 Impact Analysis, By Type, By Route of Administration, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,456,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,375,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,746,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 제네릭 의약품 시장 규모는 2022년 3,617억 1,000만 달러에 달했으며, 2023-2030년까지 CAGR의 8.31%로 성장할 것으로 예상됩니다.

제네릭 의약품 시장 - 시장 역학

• 만성질환 증가
• 만성 질환의 유병률 증가는 제네릭 의약품 시장의 주요 촉진요인 중 하나입니다. 만성질환을 진단받는 사람들이 늘어남에 따라 치료를 위해 추가 의약품을 찾게 됩니다. 브랜드 의약품은 고가이지만, 제네릭 의약품은 저렴하고 브랜드 의약품과 동일한 화학 구조를 가지고 있습니다. 환자들은 제네릭 의약품의 저렴한 비용, 화학적 구성의 일관성, 높은 효능으로 인해 브랜드 의약품보다 제네릭 의약품을 선택합니다. 만성 질환의 치료 기간이 길어지면서 제네릭 의약품의 매출도 증가하고 있습니다. 예를 들어, 세계보건기구(WHO)는 향후 10년간 만성질환으로 인한 사망자 수가 17% 증가할 것으로 예상하고 있습니다.

제네릭 의약품 시장 - 세분화 분석

• 세계 제네릭 의약품 시장은 유형, 투여 경로, 제품, 용도, 지역별로 분류됩니다.
• 시장은 유형별로 단순 제네릭, 스페셜티 제네릭, 바이오시밀러로 나뉩니다. 시장을 독점하고 있는 것은 단순 제네릭 의약품입니다. 단순 제네릭 의약품은 생물학적 동등성 시험을 실시해야 하며, 명확한 개발 계획과 규제 접근이 필요합니다. 이들 품목은 화학적으로 표준품과 동일하며, 시장은 이미 단순 제네릭 의약품으로 넘쳐나고 있습니다. 그럼에도 불구하고, 의약품에 대한 의료비 지출을 줄이고 신규 승인과 출시를 늘리려는 정부의 시도로 인해 시장은 확대될 것으로 예상됩니다.
• 시장은 투여 경로에 따라 경구제, 주사제, 흡입제, 기타로 나뉩니다. 경구용 부문이 시장을 독점하고 있습니다. 경구 투여의 편리함과 간호가 필요 없는 등 많은 장점이 환자의 수용성과 순응도를 높이고 있으며, 코로나19 환자 치료를 위해 Zenera Pharma는 2022년 9월 팍스로비드의 제네릭 의약품을 출시했습니다. 닐마트루비르 20정 포함, 이 경구약 1상자의 가격은 63.74달러입니다.

제네릭 의약품 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역들은 사업 운영 국가에 따라 더 세분화되어 있습니다. 제네릭 의약품의 제품 출시 및 수요 증가와 함께 유리한 정부 이니셔티브 증가는 북미의 주요 수익 요인으로 작용하고 있습니다.

제네릭 의약품 시장 - 경쟁 구도

• 향후 몇 년동안 공조 수요가 지속적으로 개척됨에 따라 공대공 히트 펌프 세계 시장은 해외 제조업체와 현지 제조업체로 구성되어 있으며 세계에서 가장 경쟁이 치열한 분야 중 하나가되었습니다. 각 회사는 기업 웹 사이트, 전자상거래 웹 사이트, 소매 업체, 유통 업체 및 최종 소비자와 같은 다양한 채널을 통해 제품을 판매합니다. 제품 제조업체들은 제품 비용, 성능, 제품 제작, 유통, 평판, 가용성 등 다양한 측면에서 경쟁하고 있습니다.
• 기업이 도달 범위를 강화하고 시장 점유율을 확대하기 위해 사용하는 주요 방법에는 신제품 출시, 제품 네트워크 개발, 연구 개발 비용, M&A 등이 있습니다. 예를 들어, 2022년 11월 미국 보건당국은 글렌마크제약에 우레아 사이클 장애 치료제인 페닐부티르산 나트륨 정제의 미국 내 판매 허가를 부여했습니다.

목차

제1장 제네릭 의약품 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 제네릭 의약품 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 제네릭 의약품 산업 조사

• PEST 분석
• Porter의 Five Forces 분석
• 성장 전망 매핑
• 규제 구조 분석

제5장 제네릭 의약품 시장 : COVID-19의 영향 분석

• 신형 코로나바이러스 이전의 영향 분석
• 신형 코로나바이러스 이후의 영향 분석

제6장 제네릭 의약품 시장 구도

• 제네릭 의약품 시장 점유율 분석, 2022년
• 주요 제조업체별 분석 데이터
  • 기존 기업 분석
  • 신규 기업 분석

제7장 제네릭 의약품 시장 - 유형별

• 개요
  • 유형별 부문 점유율 분석
  • 신프르제네릭스
  • 스페셜티 제네릭
  • 바이오시밀러

제8장 제네릭 의약품 시장 - 투여 경로별

• 개요
  • 투여 경로별 부문 점유율 분석
  • 경구
  • 주사
  • 흡입
  • 기타

제9장 제네릭 의약품 시장 - 제품별

• 개요
  • 제품별 부문 점유율 분석
  • 저분자
  • 고분자

제10장 제네릭 의약품 시장 - 용도별

• 개요
  • 용도별 부문 점유율 분석
  • 중추신경계 질환
  • 호흡기 질환
  • 호르몬 및 관련 질환
  • 소화기 질환
  • 심혈관 질환
  • 감염증
  • 암
  • 당뇨병
  • 기타

제11장 제네릭 의약품 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제12장 주요 벤더 분석 - 제네릭 의약품 업계

• 경쟁 대시보드
• 기업 개요
  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz(a subsidiary of Novartis)
  • Mylan(now part of Viatris)
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Endo International(through its subsidiary Par Pharmaceutical)
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Apotex

제13장 애널리스트 전방위 전망

LSH

영문 목차

영문목차

REPORT HIGHLIGHT

Generic Pharmaceuticals Market size was valued at USD 361,701.0 Million in 2022, expanding at a CAGR of 8.31% from 2023 to 2030.

Generic medicines are non-branded drugs with the same active components, dosage form, potency, and intended purpose as brand-name drugs. Following the termination of the patent protection for the original medicine, these products are created and marketed. To assure their safety, quality, and efficacy, generic medications must pass stringent regulatory clearance procedures. Generic medicines are often less expensive than name-brand medications since there are no expenditures associated with research and development. While preserving similar therapeutic efficacy to their branded versions, they help extend access to vital pharmaceuticals and are crucial in lowering healthcare costs.

Generic Pharmaceuticals Market- Market Dynamics:

• Increasing incidence of chronic diseases.

• The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more people are given a chronic disease diagnosis, they seek out additional medications to treat it. Branded medications cost more, whereas generic medications cost less and share the same chemical make-up as branded medications. Patients choose generic medications over branded medications due to the lower cost, consistency in chemical makeup, and potency of generic medications. As a result of the extended duration of therapy for chronic diseases, generic medicine sales also rise. For instance, the WHO (World Health Organization) predicts a 17% rise in the number of chronic disease-related fatalities during the next ten years.

Generic Pharmaceuticals Market- Key Insights:

• As per the analysis shared by our research analyst, the global generic pharmaceutical market is estimated to grow annually at a CAGR of around 8.31% over the forecast period (2023-2030)

• Based on type segmentation, simple generic products were predicted to show maximum market share in the year 2022

• Based on application, cardiovascular was the leading type in 2022

• Based on product segmentation, the small molecule was the leading type in 2022

• Based on route of administration segmentation, oral was the leading type in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Generic Pharmaceuticals Market- Segmentation Analysis:

• The Global Generic Pharmaceuticals Market is segmented based on Type, Route of Administration, Product, Application, and Region.

• The market is divided into categories based on Type: Simple Generics, Specialty Generics, and Biosimilars. The Simple Generics sector dominates the market. The simple generic products need to conduct bioequivalence studies and have a defined development plan and regulatory approach. These items are chemically identical to their reference counterparts, and the market is already overflowing with straightforward generic products. Nevertheless, the market is anticipated to expand as a result of government attempts to cut healthcare spending on medicines and increase new approvals and launches.

• The market is divided into categories based on Route of Administration: Oral, Injectable, Inhalable, and Others. The oral segment dominates the market. The many benefits of oral dose, including its simplicity and lack of nursing needs, increase patient acceptance and compliance. For the treatment of COVID-19 patients, Zenera Pharma introduced a generic version of Paxlovid in September 2022. Each box of these oral medications, which contains 20 Nirmatrelvir pills, costs USD 63.74.

Generic Pharmaceuticals Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. An increasing number of favorable government initiatives coupled with the rising number of product launches and demand for generic drugs is a key revenue driver in North American region.

Generic Pharmaceuticals Market- Competitive Landscape:

• Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution, reputation, and availability.

• Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, Product network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The US health authority gave Glenmark Pharmaceuticals permission to sell sodium phenylbutyrate tablets, a medication used to treat urea cycle disorders, in the US.

Recent Developments:

In October 2022, Generic Fingolimod capsules, utilized for the treatment of multiple sclerosis, were introduced to the American market by Glenmark's American-based division.

Key features of the study:

• This proposed research study on Generic Pharmaceuticals market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

• The report provides the client the latest up-to-date and trending insights about the Generic Pharmaceuticals market.

• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Generic Pharmaceuticals market

• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Generic Pharmaceuticals market

• Impact of COVID-19 on Generic Pharmaceuticals market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Generic Pharmaceuticals market post-COVID will also be covered.

• In order to give the users of this report a comprehensive view on the Generic Pharmaceuticals market, we have also included competitive landscape and key innovator analysis for the Generic Pharmaceuticals market.

• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

• The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Generic Pharmaceuticals market.

• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

• The global Generic Pharmaceuticals market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC PHARMACEUTICALS MARKET KEY PLAYERS

• Zydus Cadila
• Torrent Pharmaceuticals
• Teva Pharmaceutical Industries
• Sun Pharmaceutical Industries
• Sandoz (a subsidiary of Novartis)
• Mylan (now part of Viatris)
• Lupin Pharmaceuticals
• Hikma Pharmaceuticals
• Glenmark Pharmaceuticals
• Fresenius Kabi
• Endo International (through its subsidiary Par Pharmaceutical)
• Dr. Reddy's Laboratories
• Cipla
• Aurobindo Pharma
• Apotex

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE

• Simple Generics
• Specialty Generics
• Biosimilars

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

• Oral
• Injectable
• Inhalable
• Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT

• Small Molecule
• Large Molecule

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION

• Central Nervous System Disorders
• Respiratory Diseases
• Hormones & Related Diseases
• Gastrointestinal Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Cancer
• Diabetes
• Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Generic Pharmaceuticals Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Generic Pharmaceuticals Market Snippet by Type
  • 2.1.2. Generic Pharmaceuticals Market Snippet by Route of Administration
  • 2.1.3. Generic Pharmaceuticals Market Snippet by Product
  • 2.1.4. Generic Pharmaceuticals Market Snippet by Application
  • 2.1.5. Generic Pharmaceuticals Market Snippet by Country
  • 2.1.6. Generic Pharmaceuticals Market Snippet by Region
• 2.2. Competitive Insights

3. Generic Pharmaceuticals Key Market Trends

• 3.1. Generic Pharmaceuticals Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Generic Pharmaceuticals Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Generic Pharmaceuticals Market Opportunities
• 3.4. Generic Pharmaceuticals Market Future Trends

4. Generic Pharmaceuticals Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Generic Pharmaceuticals Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Generic Pharmaceuticals Market Landscape

• 6.1. Generic Pharmaceuticals Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Generic Pharmaceuticals Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
  • 7.1.2. Simple Generics
  • 7.1.3. Specialty Generics
  • 7.1.4. Biosimilars

8. Generic Pharmaceuticals Market - By Route of Administration

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 8.1.2. Oral
  • 8.1.3. Injectable
  • 8.1.4. Inhalable
  • 8.1.5. Others

9. Generic Pharmaceuticals Market - By Product

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
  • 9.1.2. Small Molecule
  • 9.1.3. Large Molecule

10. Generic Pharmaceuticals Market - By Application

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
  • 10.1.2. Central Nervous System Disorders
  • 10.1.3. Respiratory Diseases
  • 10.1.4. Hormones & Related Diseases
  • 10.1.5. Gastrointestinal Diseases
  • 10.1.6. Cardiovascular Diseases
  • 10.1.7. Infectious Diseases
  • 10.1.8. Cancer
  • 10.1.9. Diabetes
  • 10.1.10. Others

11. Generic Pharmaceuticals Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Generic Pharmaceuticals Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Generic Pharmaceuticals Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Generic Pharmaceuticals Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Generic Pharmaceuticals Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Generic Pharmaceuticals Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Generic Pharmaceuticals Industry

• 12.1. Competitive Dashboard
• 12.2. Company Profiles
  • 12.2.1. Zydus Cadila
  • 12.2.2. Torrent Pharmaceuticals
  • 12.2.3. Teva Pharmaceutical Industries
  • 12.2.4. Sun Pharmaceutical Industries
  • 12.2.5. Sandoz (a subsidiary of Novartis)
  • 12.2.6. Mylan (now part of Viatris)
  • 12.2.7. Lupin Pharmaceuticals
  • 12.2.8. Hikma Pharmaceuticals
  • 12.2.9. Glenmark Pharmaceuticals
  • 12.2.10. Fresenius Kabi
  • 12.2.11. Endo International (through its subsidiary Par Pharmaceutical)
  • 12.2.12. Dr. Reddy's Laboratories
  • 12.2.13. Cipla
  • 12.2.14. Aurobindo Pharma
  • 12.2.15. Apotex

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us

관련자료